Acyclic Nucleosides Other Than Acyclovir as Potential Antiviral Agents

Nucleosides and Nucleotides

Volumn 4, Issue 3, 1985, Pages 411-427

  Remy, Richard J ^a   Secrist, John A ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84936300247     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328318508056172     Document Type: Article

References (156)

1. Colla, L., De Clercq, E., Busson, R., and Vanderhaeghe, H. Synthesis and antiviral activity of water-soluble esters of acyclovir [9-[(2-hydroxyethoxy)methyl] - guanine]. J. Med. Chem., 26, 602–604 (1983).
2. Good, S. S., Krasny, H. C., Elion, G. B., and de Miranda, P. Disposition in the dog and the rat of 2,6-diamino-9-(2-hydroxyethoxymethyl)purine (A134U), a potential prodrug of acyclovir. J. Pharmacol. Exp. Ther., 227, 644–651 (1983).
3. Krenitsky, T. A., Hall, W. W., de Miranda, P., Beauchamp, L. M., Schaeffer, H. J., and Whiteman, P. D. 6-Deoxyacyclovir: A xanthine oxidase-activated prodrug of acyclovir. Proc. Natl. Acad. Sci. USA, 81, 3209–3213 (1984)
4. Maudgal, P. C., De Clercq, E., Descamps, J., and Missotten, L. Topical treatment of experimental herpes simplex keratouveitis with 2!-0-glycylacyclovir. Arch. Ophthalmol,, 102, 140–142 (1984).
5. Quinn, R. P., Good, S. S., Gerald, L., and Sabatka, J. J. A single-tube radioimmunoassay for the antiviral agent 2,6-diamino-9-(2-hydroxyethoxy-methyl)purine (A134U). Anal. Biochem., 16–25 (1983).
6. Spector, T., Jones, T. E., and Beacham, L. M., III. Conversion of 2,6-diamino-9-(2-hydroxyethoxymethyl)purine to acyclovir as catalyzed by adenosine deaminase. Biochem. Pharmacol., 32, 2505–2509 (1983).
7. Tyms, A. S., Seamans, E. M., and Naim, H. M. The in vitro activity of acyclovir and related compounds against cytomegalovirus infections. J. Antimicrob. Chemother., 8, 65–72 (1981)
8. Barrio, J. R., Bryant, J. D., and Keyser, G. E. A direct method for the preparation of 2-hydroxyethoxymethyl derivatives of guanine, adenine, and cytosine. J. Med. Chem., 23, 572–574 (1980).
9. Bryant, J. D., Keyser, G. E., and Barrio, J. R. Acyclic nucleoside analogues: Synthesis of open-ring riboside or deoxyriboside analogues lacking C(3' ‘) or the C(3f)-C(4' ‘) bond. J. Qrg. Chem., 44, 3733–3734 (1979).
10. Griengl, H., Hayden, W., Schindler, E., and Wanek, E. Cyclic aldehyde derivatives as alkylating reagents, I. Acyclo and azaacyclo analogs of nucleosides. Arch. Pharm., 316, 146–153 (1983).
11. Holy, A. Synthesis of N-(2,3-dihydroxy propyl) derivatives of heterocyclic bases. Collect. Czech. Chem. Commun., 43, 2054–2061 (1978).
12. Holy, A. Synthesis of new mono- and disubstituted hydroxyalkyl and aminoalkyl derivatives of heterocyclic bases. Collect. Czech. Chem. Commun., 43, 3444–3465 (1978).
13. Holy, A. Preparation of aliphatic analogues of S-adenosyl-L-homocysteine and related compounds. Collect. Czech. Chem. Commun., 46, 3134–3144 (1981).
14. Holy, A. Preparation of enantiomeric and racemic 2,3,4,5-tetrahydroxypentyl derivatives of adenine, cytosine, and uracil. Collect. Czech. Chem. Commun., 47, 2786–2805 (1982).
15. Keyser, G. E., Bryant, J. D., and Barrio, J. R. Iodomethylethers from 1,3-dioxolane and 1,3-oxathiolane: Preparation of acyclic nucleoside analogs. Tetrahedron Lett., 3263–3264 (1979).
16. Robins, M. J. and Hatfield, P. W. Nucleic acid related compounds. 37. Convenient and high-yield syntheses of N-[(2-hydroxyethoxy)methyl] heterocycles as “acyclic nucleoside” analogues. Can. J. Chem., 60, 547–553 (1982).
17. Tychinskaya, L. Y. and FlorenPev, V. L. Synthesis of 9-()3-hydroxyethoxymethyl)-adenine and l-(3-hydroxyethoxymethyl)cytosine. Bioorg. Khim., 4, 1461–1463 (1978); Chem. Abstr., 90, 87404q (1978). Ashton, W. T., Karkas, J. D., Field, A. K., and Tolman, R. L. Activation by thymidine kinase and potent antiherpetic activity of 2T-nor-2?-deoxy-guanosine (2f-NDG). Biochem. Biophys. Res. Commun., 108, 1716–1721 (1982).
18. Boehme, R. E. Phosphorylation of the antiviral precursor 9-(l,3-dihydroxy-2-propoxymethyl)guanine monophosphate by guanylate kinase isozymes. J. Biol. Chem., 259, 12346–12349 (1984).
19. Cheng, Y.-C., Grill, S. P., Dutschman, G. E., Frank, K. B., Chiou, J.-F., Bastow, K. F., and Nakayama, K. Effects of 9-(l,3-dihydroxy-2-propoxymethyl)-guanine, a new antiherpesvirus compound, on synthesis of macromolecules in herpes simplex virus-infected cells. Antimicrob. Agents Chemother., 26, 283–288 (1984).
20. Cheng, Y.C., Grill, S. P., Dutschman, G. E., Nakayama, K., and Bastow, K. F. Metabolism of 9-(l,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells. J. Biol. Chem., 258, 12460–12464 (1983).
21. Cheng, Y.C., Huang, E.S., Lin, J.C., Mar, E.C., Pagano, J. S., Dutschman, G. E., and Grill, S. P. Unique spectrum of activity of 9-[(l,3-dihydroxy-2-propoxy)methyl] guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA, 80, 2767–2770 (1983).
22. Crumpacker, C. S., Kowalsky, P. N., Oliver, S. A., Schnipper, L. E., and Field, A. K. Resistance of herpes simplex virus to 9-{[2-hydroxy-l-(hydroxymethyl)-ethoxy] methyljguanine: Physical mapping of drug synergism within the viral DNA polymerase locus. Proc. Natl. Acad. Sci. USA, 81, 1556–1560 (1984).
23. Davies, M.E. M., Bondi, J. V., and Field, A. K. Efficacy of 2f-nor-2'-deoxyguanosine treatment for orofacial herpes simplex virus type 1 skin infections in mice. Antimicrob. Agents Chemother., 25, 238–241 (1984).
24. Eppstein, D. A. and Marsh, Y. V. Potent synergistic inhibition of herpes simplex virus-2 by 9-[(l,3-dihydroxy-2-propoxy)methyl] guanine in combination with recombinant interferons. Biochem. Biophys. Res. Commun., 120, 66–73 (1984).
25. Field, A. K., Davies, M. E., DeWitt, C., Perry, H. C., Liou, R., Germershausen, J., Karkas, J. D., Ashton, W. T., Johnston, D. B. R., and Tolman, R. L. 9-{[2-Hydroxy-l-(hydroxymethyl)ethoxy) methyOguanine: A selective inhibitor of herpes group virus replication. Proc. Natl. Acad. Sci. USA, 80, 4139–4143 (1983).
26. Field, H. J., Anderson, J. R., and Efstathiou, S. A quantitative study of the effects of several nucleoside analogues on established herpes encephalitis in mice. J. Gen. Virol., 65, 707–719 (1984).
27. Frank, K. B., Chiou, J.-F., and Cheng, Y.-C. Interaction of herpes simplex virus-induced DNA polym erase with 9-(1,3-dihydroxy-2-propoxym ethyUguanine triphosphate. J. Biol. Chem., 259, 1566–1569 (1984).
28. Fraser-Smith, E. B., Eppstein, D. A., Marsh, Y. V., and Matthews, T. R. Enhanced efficacy of the acyclic nucleoside 9-(l,3-dihydroxy-2-propoxymethyl)guanine in combination with beta-interferon against herpes simplex virus type 2 in mice. Antimicrob. Agents Chemother., 25, 563–565 (1984).
29. Fraser-Smith, E. B., Eppstein, D. A., Marsh, Y. V., and Matthews, T. R. Enhanced efficacy of the acyclic nucleoside 9-(l,3-dihydroxy-2-propoxymethyl)guanine in combination with alpha-interferon against herpes simplex virus type 2 in mice. Antimicrob. Agents Chemother., 26, 937–938 (1984).
30. Fraser-Smith, E. B., Smee, D. F., and Matthews, T. R. Efficacy of the acyclic nucleoside 9-(l,3-dihydroxy-2-propoxymethyl)guanine against primary and recrudescent genital herpes simplex virus type 2 infections in guinea pigs. Antimicrob. Agents Chemother., 24, 883–887 (1983).
31. Gauntt, C. J., Arizpe, H. M., Kung, J. T., Ogilvie, K. K., and Cheriyan, U. O. Antimyocarditic activity of the guanine derivative B1OLF-70 in a coxsackie virus B3 murine model. Antimicrob. Agents Chemother., 27, 184–191 (1985)
32. Germershausen, J., Bostedor, R., Field, A. K., Perry, H., Liou, R., Bull, H., Tolman, R. L., and Karkas, J. D. A comparison of the antiviral agents 2'-nor-2t-deoxyguanosine and acyclovir: Uptake and phosphorylation in tissue culture and kinetics of in vitro inhibition of viral and cellular DNA polymerases by their respective triphosphates. Biochem. Biophys. Res. Commun., 116, 360–367 (1983).
33. Lin, J.-C., Smith, M. C., and Pagano, J. S. Prolonged inhibitory effect of 9-(l,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J. Virol., 50, 50–55 (1984).
34. Lin, T.-S. and Liu, M.-C. Synthesis of 9-(2,3-dihydroxy-l-propoxymethyl)guanine -- A new potential antiviral agent. Tetrahedron Lett., 25, 905–906 (1984).
35. Mar, E.-C., Cheng, Y.-C., and Huang, E.-S. Effect of 9-(l,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro. Antimicrob. Agents Chemother., 24, 518–521 (1983).
36. Martin, J. C., Dvorak, C. A., Smee, D. F., Matthews, T. R., and Verheyden, J. P. H. 9- [(l,3-Dihydroxy-2-propoxy)methyl] guanine: A new potent and selective antiherpes agent. J. Med. Chem., 26, 759–761 (1983).
37. Martin, J. C., Jeffrey, G. A., McGee, D. P. C., Tippie, M. A., Smee, D. F., Matthews, T. R., and Verheyden, J. P. H. Acyclic analogues of 2T-deoxynucleosides related to 9-[(l,3-dihydroxy-2-propoxy)methyl] guanine as potential antiviral agents. J. Med. Chem., 28, 358–362 (1985).
38. Oberg, B. and Johansson, N.-G. The relative merits and drawbacks of new nucleoside analogues with clinical potential. J. Antimicrob. Chemother., 14 (Suppl. A), 5–26 (1984).
39. Ogilvie, K. K., Cheriyan, U. O., Radatus, B. K., Smith, K. O., Galloway, K. S., and Kennell, W. L. Biologically active acyclonucleoside analogues. II. The synthesis of 9- [[2-hydroxy-l-(hydroxymethyl)ethoxy] methyl] guanine (BIOLF-62). Can. J. Chem., 60, 3005–3010 (1982).
40. Rasmussen, L., Chen, P. T., Mullenax, J. G., and Merigan, T. C. Inhibition of human cytom egalovirus replication by 9-(1,3-dihydroxy-2-propoxym ethyl) guanine alone and in combination with human interferons. Antimicrob. Agents Chemother., 26, 441–445 (1984).
41. Rollinson, E. A. and White, G. Relative activities of acyclovir and BW759 against Aujesky's disease and equine rhinopneumonitis viruses. Antimicrob. Agents Chemother., 24, 221–226 (1983).
42. St. Clair, M. H., Miller, W. H., Miller, R. L., Lambe, C. U., and Furman, P. A. Inhibition of cellular a DNA polymerase and herpes simplex virus-induced DNA polymerases by the triphosphate of BW759U. Antimicrob. Agents Chemother., 25, 191–194 (1984).
43. Smee, D. F., Knight, S. S., Duke, A. E., Robinson, W. S., Matthews, T. R., and Marion, P. L. Activities of arabinosyladenine monophosphate and 9—(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase. Antimicrob. Agents Chemother., 27, 277–279 (1985).
44. Smee, D. F., Martin, J. C., Verheyden, J. P. H., and Matthews, T. R. Anti-herpesvirus activity of the acyclic nucleoside 9-(l,3-dihydroxy-2-propoxy-methyl)guanine. Antimicrob. Agents Chemother., 23, 676–682 (1983).
45. Smith, K. O., Galloway, K. S., Hodges, S. L., Ogilvie, K. K., Radatus, B. K., Kalter, S. S., and Heberling, R. L. Sensitivity of equine herpesviruses 1 and 3 in vitro to a new nucleoside analog, 9-[[2-hydroxy-l-(hydroxymethyl)-ethoxy] methyl] guanine. Am. J. Vet. Res., 44, 1032–1035 (1983).
46. Smith, K. O., Galloway, K. S., Kennell, W. L., Ogilvie, K. K., and Radatus, B. K. A new nucleoside analog, 9-[[2-hydroxy-l-(hydroxymethyl)ethoxy] methyl] - guanine, highly active in vitro against herpes simplex virus types 1 and 2. Antimicrob. Agents Chemother., 22, 55–61 (1982).
47. Smith, K. O., Galloway, K. S., Ogilvie, K. K., and Cheriyan, U. O. Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds. Antimicrob. Agents Chemother., 22, 1026–1030 (1982).
48. Smith, K. O., Hodges, S. L., Kennell, W. L., Galloway, K. S., Poirier, R. H., Ogilvie, K. K., and Cheriyan, U. O. Experimental ocular herpetic infections in rabbits. Treatment with 9-([2-hydroxy-l-(hydroxymethyl)ethoxy] - methyl)guanine. Arch. Ophthalmol., 102, 778–781 (1984).
49. Tocci, M. J., Livelli, T. J., Perry, H. C., Crumpacker, C. S., and Field, A. K. Effects of the nucleoside analog 2T-nor-2'-deoxyguanosine on human cytomegalovirus replication. Antimicrob. Agents Chemother., 25, 247–252 (1984).
50. Trousdale, M. D., Nesburn, A. B., Willey, D. E., and Taaid, H. Efficacy of BW759 (9-[[2-hydroxy-l-(hydroxymethyl)ethoxy] methyl] guanine) against herpes simplex virus type 1 keratitis in rabbits. Curr. Eye Res., 3, 1007–1015 (1984).
51. Bussereau, F. and Ermine, A. Effects of heteropolyanions and nucleoside analogs on rabies virus — In vitro study of syntheses and viral production. Ann. Virol., 134E, 487–506 (1983); Chem. Abstr., 100, 171424d (1983)
52. Cihak, A. and Holy, A. Distribution and metabolic transformation of 9-(S)—(2,3—dihydroxypropyl)adenine, an effective virostatic agent, in mice. Collect. Czech. Chem. Commun., 43, 2082–2088 (1978).
53. De Clercq, E., Bergstrom, D. E., Holy, A., and Montgomery, J. A. Broad-spectrum antiviral activity of adenosine analogues. Antiviral Res., 4, 119–133 (1984).
54. De Clercq, E., Descamps, J., De Somer, P., and Holy, A. (S)-9-(2,3-Dihydroxy-propyl)adenine: An aliphatic nucleoside analog with broad-spectrum antiviral activity. Science, 200, 563–565 (1978).
55. De Clercq, E. Leyten, R., Sobis, H., Matousek, J., Holy, A., and De Somer, P. Inhibitory effect of a broad-spectrum antiviral agent, (S)-9-(2,3-dihydroxy-propyl)adenine, on spermatogenesis in mice. Toxicol. Appl. Pharmacol., 59, 441–451 (1981).
56. Dragun, M., Rada, B., and Holy, A. Transport of antiviral agent 9-(S)-(2,3-dihydroxypropyl)adenine to animal cells. Acta Virol., 27, 119–129 (1983).
57. Gresikova, M., Rada, B., and Holy, A. Studies on the effect of 9-(R, S)-(2,3-dihydroxypropyl)adenine on tick-borne encephalitis virus. Acta Virol., 26, 521–523 (1982).
58. Gurskaya, G. V., Dzhavadova, G. M., Vasiliev, D. G., Tsilevich, T. L., Zavgorodny, S. G., and Florentiev, V. L. X-Ray study of the antiviral compound (S)-9-(2,3-dihydroxypropyl)adenine. Bioorg. Khim., 10, 1414–1420 (1984).
59. Havlas, Z., Hrebabecky, H., and Beranek, J. Quantum chemical calculation of the (S)-9-(2,3-dihydroxypropyl)adenine molecule. Nucleic Acids Res., 8, 6233–6238 (1980).
60. Holy, A. Novel adenosine analogs with broad-spectrum biological activity: Structure and mechanism of action. Nucleic Acids Symp. Ser., 11, 199–202 (1982).
61. Holy, A. and Cihak, A. Metabolism of 9-(S)-(2,3-dihydroxypropyl)adenine, an antiviral agent, in mice. Biochem. Pharmacol., 30, 2359–2361 (1981).
62. Jelinek, R., Holy, A., and Votruba, I. Embryotoxicity of 9-(S)-(2,3-dihydroxy-propyl)adenine. Tetratology, 24, 267–275 (1981).
63. Kara, J., Vacha, P., and Holy, A. 9-(S)-(2,3-dihydroxypropyl)adenine inhibits the transformation of chick embryo fibroblasts infected with Rous sarcoma virus. Evidence for inhibition of enzymatic activity of isolated cellular protein kinases by the drug. FEBS Lett., 107, 187–192 (1979).
64. King, G. S. D. and Sengier, L. Crystal structures of two forms of 9-(2,3-dihydroxypropyl)adenine. J. Chem. Res. (S), 121 (1981).
65. Rada, B., Dragun, M., Votruba, I., and Holy, A. Characteristics of the antiviral effect of 9-(S)-(2,3-dihydroxypropyl)adenine. Acta Virol., 24, 433–438 (1980).
66. Rada, B. and Holy, A. Virus inhibitory effect of combination of 9-(S)-(2,3-dihydroxypropyl)adenine and 6-azauridine. Chemotherapy, 26, 184–190 (1980).
67. Slama, K., Holy, A., and Votruba, I. Insect sterility induced by a broad-spectrum antiviral agent (S)-9-(2,3-dihydroxypropyl)adenine. Entomol. Exp. Appl., 33, 9–14 (1983).
68. Smee, D. F., Sidwell, R. W., Clark, S. M., Barnett, B. B., and Spendlove, R. S. Inhibition of reoviruses in vitro by selected antiviral substances. Antiviral Res., 1, 315–323 (1981).
69. Smee, D. F., Sidwell, R. W., Clark, S. M., Barnett, B. B., and Spendlove, R. S. Inhibition of rotaviruses by selected antiviral substances: Mechanisms of viral inhibition and in vivo activity. Antimicrob. Agents Chemother., 21, 66–73 (1982).
70. Smee, D. F., Sidwell, R. W., Clark, S. M., Barnett, B. B., and Spendlove, R. S. Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances. Antimicrob. Agents Chemother., 20, 533–538 (1981).
71. Sodja, I. and Holy, A. Effect of 9-(S)-(2,3-dihydroxypropyl)adenine on experimental rabies infection in laboratory mice. Acta Virol., 24, 317–324 (1980).
72. Votruba, I. and Holy A. Inhibition of S-adenosyl-L-homocysteine hydrolase by the aliphatic nucleoside analog 9-(S)-(2,3-dihydroxypropyl)adenine. Collect. Czech. Chem. Commun., 45, 3039–3044 (1980).
73. Votruba, I., Holy, A., and De Clercq, E. Metabolism of the broad-spectrum antiviral agent, 9-(S)-(2,3-dihydroxypropyl)adenine, in different cell lines. Acta Virol., 27, 273–276 (1983).
74. Wingard, J. R., Hess, A. D., Stuart, R. K., Saral, R., and Burns, W. H. Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation. Antimicrob. Agents Chemother., 23, 593–597 (1983).
75. De Clercq, E., Descamps, J. Verhelst, G., Walker, R. T., Jones, A. S., Torrence, P. F., and Shugar, D. Comparative efficacy of antiherpes drugs against
76. different strains of herpes simplex virus. J. Infect. Dis., 141, 563–574 (1980).
77. North, T. W. and Cohen, S. S. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues. Proc. Natl. Acad. Sci. USA, 75, 4684–4688 (1978).
78. North, T. W., O’Connor, L., Abushanab, E., and Panzica, R. P. Effects of chirality in 9-(2-hydroxy-3-nonyl)adenine upon deoxyribonucleic acid synthesis in herpes simplex virus-infected cells. Biochem. Pharmacol., 32, 3541–3546 (1983).
79. Shannon, W. M., Arnett, G., Schabel, F. M., Jr., North, T. W., and Cohen, S. S. Erythro-9-(2-Hydroxy-3-nonyl)adenine alone and in combination with 9-/3-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice. Antimicrob. Agents Chemother., 18, 598–603 (1980).
80. Shigeta, S., Yokota, T., Iwabuchi, T., Baba, M., Konno, K., Ogata, M., and De Clercq, E. Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus. J. Infect. Dis., 147, 576–584 (1983)
81. Bussereau, F., Chermann, J. C., De Clercq, E., and Hannoun, C. Search for compounds which have an inhibitory effect on rhabdovirus multiplication in vitro. Ann. Virol., 134E, 127–134 (1983).
82. Colla, L., Busson, R., De Clercq, E., and Vanderhaeghe, H. Synthesis of aliphatic nucleoside analogues with potential antiviral activity. Eur. J. Med. Chem. - Chim. Ther., 569–576 (1982).
83. De Clercq, E. and Holy, A. Antiviral activity of aliphatic nucleoside analogues: Structure-function relationship. J. Med. Chem., 22, 510–513 (1979).
84. De Clercq, E. and Holy, A. Alkyl esters of 3-adenin-9-yl-2-hydroxypropanoic acid: A new class of broad-spectrum antiviral agents. J. Med. Chem., 28, 282–287 (1985).
85. Fyfe, J. A., McKee, S. A., and Keller, P. M. Altered thymidine-thymidylate kinases from strains of herpes simplex virus with modified drug sensitivities to acyclovir and (E)-5-(2-bromovinyl)-2T-deoxyuridine. Mol. Pharmacol., 24, 316–323 (1983).
86. Holy, A. Synthesis of some 2,3-dihydroxypropyl derivatives of purine bases. Collect. Czech. Chem. Commun., 43, 3103–3117 (1978)
87. Holy, A. Synthesis of racemic and optically active erythro- and threo-9-(2,3,4-trihydroxybutyl)adenines and related compounds. Collect. Czech. Chem. Commun., 44, 593–612 (1979).
88. Holy, A. Stereospecific synthesis of isomeric 4-substituted 9-(2,3-dihydroxy-butyl)adenines. Collect. Czech. Chem. Commun., 47, 173–189 (1982).
89. Holy, A. Synthesis of eight stereoisomeric 5-(adenin-9-yl)-2,3,4-trihydroxy-pentanoic acids. Collect. Czech. Chem. Commun., 47, 2969–2988 (1982).
90. Holy, A. Novel adenosine analogs with broad-spectrum biological activity: Structure and mechanism of action. Nucleic Acids Symp. Ser., 11, 199–202 (1982).
91. Holy, A. Preparation of isomeric 3-aminopropylamino derivatives of 9-(RS)-(2,3-dihydroxypropyDadenine. Collect. Czech. Chem. Commun., 48, 1910–1921 (1983).
92. Holy, A., Votruba, I., and De Clercq, E. Synthesis and antiviral activity of stereoisomeric eritadenines. Collect. Czech. Chem. Commun., 47, 1392–1407 (1982).
93. Kadir, K., Shaw, G., and Wright, D. Purines, pyrimidines, and imidazoles. Part 56. Some aminoimidazolecarboxamidines and derived adenines. J. Chem. Soc., Perk. Trans. 1, 2728–2731 (1980).
94. Keller, P. M., Fyfe, J. A., Beauchamp, L., Lubbers, C. M., Furman, P. A., Schaeffer, H. J., and Elion, G. B. Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem. Pharmacol., 30, 3071–3077 (1981).
95. Kelley, J. L., Miller, C. A., and Schaeffer, H. J. Acyclic puromycin analogs: 9-[(2-Phenylalanylamidoethoxy)methyl] adenine and 9-(3-phenylalanylamido-propyDadenine. J. Pharm. Sci., 70, 1169–1171 (1981).
96. Larsson, A., Alenius, S., Johansson, N.-G., and Oberg, B. Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine. Antiviral Res., 3, 77–86 (1983).
97. Larsson, A., Brannstrom, G., and Oberg, B. Kinetic analysis in cell culture of the reversal of antiherpes activity of nucleoside analogs by thymidine. Antimicrob. Agents Chemother., 24, 819–822 (1983).
98. Larsson, A., Oberg, B., Alenius, S., Hagberg, C.-E., Johansson, N.-G., Lindborg, B., and Stening, G. 9-(3,4-Dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication. Antimicrob. Agents Chemother., 23, 664–670 (1983)
99. Larsson, A. and Tao, P.-Z. Phosphorylation of four acyclic guanosine analogs by herpes simplex virus type 2 thymidine kinase. Antimicrob. Agents Chemother., 25, 524–526 (1984).
100. Lerner, L. M. The preparation of a crystalline guanosine trialcohol and its sodium salt. Carbohydr. Res., 127, 141–145 (1984).
101. Liu, M.-C., Kuzmich, S., and Lin, T.-S. A novel method for the synthesis of 9-[[2-hydroxy-l-(aminomethyl)ethoxy] methyl] guanine — A potential antiviral agent. Tetrahedron Lett., 25, 613–616 (1984).
102. MacKenzie, G., Shaw, G., and Robinson, D. H. Purines, pyrimidines, and imidazoles. Part 46, Some acyclic D-arabinose imidazole and purine nucleosides. J. Chem. Soc., Perk. Trans. 1, 1094–1103 (1977).
103. McCormick, J. E. and McElhinney, R. S. Thio-sugars. Part 6. Seco-nucleosides related to 4-thio-DL-erythrofuranose and 4-thio-DL-ribofuranose. J. Chem. Res. (S), 12–13 (1981).
104. McCormick, J. E. and McElhinney, R. S. Thio sugars. Part 9, Antiviral nucleosides from 4-thio-DL-erythrofuranose and purines and other fused pyrimidines. Proc. R. Ir. Acad., Sect. B, 83, 125–138 (1983); Chem. Abstr., 100, 22947z (1983).
105. Oberg, B. and Johansson, N.-G. The relative merits and drawbacks of new nucleoside analogues with clinical potential. J. Antimicrob. Chemother., 14, (Suppl. A), 5–26 (1984).
106. Ogilvie, K. K. and Gillen, M. F. Ring open analogues of deoxynucleotides. Tetrahedron Lett., 21, 327–330 (1980).
107. Ogilvie, K. K. and Hanna, H. R. Synthesis of antiviral compounds. Preparation and rearrangement of 6-methoxyglyceropurines. Can. J. Chem., 62, 2702–2706 (1984).
108. Ogilvie, K. K., Nguyen-Ba, N., Gillen, M. F., Radatus, B. K., Cheriyan, U. O., Hanna, H. R., Smith, K. O., and Galloway, K. S. Synthesis of a purine acyclonucleoside series having pronounced antiviral activity. The glyceropurines. Can. J. Chem., 62, 241–252 (1984).
109. Ogilvie, K. K., Nguyen-Ba, N, and Hamilton, R. G. A trihydroxy acyclonucleoside series. Can. J. Chem., 62, 1622–1627 (1984).
110. Ogilvie, K. K. and Proba, Z. A. Synthesis of purine and pyrimidine trihydroxy-acyclonucleosides. Nucleosides Nucleotides, 3, 537–547 (1984).
111. Parkin, A. and Harnden, M. R. Acyclic analogues of purine and imidazole nucleosides. J. Heterocycl. Chem., 19, 33–40 (1982)
112. Robins, M. J., Hatfield, P. W., Balzarini, J., and De Clercq, E. Nucleic acid related compounds, 47. Synthesis and biological activities of pyrimidine and purine “acyclic” nucleoside analogues. J. Med. Chem., 27, 1486–1492 (1984).
113. Tippie, M. A., Martin, J. C., Smee, D. F., Matthews, T. R., and Verheyden, J. P. H. Antiherpes simplex virus activity of 9-[4-hydroxy-3-(hydroxymethyl)-l-butyl] guanine. Nucleosides Nucleotides, 3, 525–535 (1984).
114. Tronchet, J. M. J. and Schwarzenbach, D. Nouveau type d!“acyclonucleosides”. Carbohydr. Res., 99, 78–81 (1982).
115. Tyms, A. S., Seamans, E. M., and Naim, H. M. The in vitro activity of acyclovir and related compounds against eytomegalovirus infections. J. Antimicrob. Chemother., 8, 65–72 (1981).
116. Votruba, I. and Holy, A. Eritadenines — Novel type of potent inhibitors of S-adenosyl-L-homocysteine hydrolase. Collect. Czech. Chem. Commun., 47, 167–172 (1982).
117. Zemlicka, J. Synthesis and biological properties of 9-(2,4-dihydroxybutyl)adenine and guanine: New analogs of 9-(2,3-dihydroxypropyl)adenine (DHPA) and 9-(2-hydroxyethoxymethyl)guanine (acyclovir). Nucleosides Nucleotides, 3, 245–264 (1984)
118. Abrams, H. M., Ho, L., and Chu, S. H. Synthesis of pyrimidine acyclonucleosides. J. Heterocycl. Chem., 18, 947–951 (1981).
119. Chu, S. H., Chen, Z. H., Rowe, E. C., Naguib, F. N. M., el Kouni, M. H., and Chu, M. Y. Synthesis and biological activity of hydroxymethyl analogs of 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine. Nucleosides Nucleotides, 3, 303–311 (1984).
120. Colla, L., Busson, R., De Clercq, E., and Vanderhaeghe, H. Synthesis of aliphatic nucleoside analogues with potential antiviral activity. Eur. J. Med. Chem. - Chim. Ther., 17, 569–576 (1982).
121. De Clercq, E. and Holy, A. Antiviral activity of aliphatic nucleoside analogues: Structure-function relationship. J. Med. Chem., 22, 510–513 (1979).
122. Eriksson, B., Oberg, B., and Gauri, K. K. Inhibition of herpes virus DNA polymerase by nucleotides derived from acyclonucleosides which do not suppress herpes virus replication. In: K. K. Gauri, editor, Antiviral Chemother.: Des. Inhib. Viral Funct., pp. 161–170, 1981
123. Karpeiskii, M. Y., Mikhailov, S. M., Tsieminya, A. S., Ziderman, A. A., Kravchenko, I. M., Lidak, M. Y., and Zhuk, R. A. Analogs of pyrimidine nucleosides. 14. Synthesis and antitumorigenic activity of alkoxyalkyl derivatives of 5-fluorouracil. Chem. Heterocycl. Compd. (Engl. Transl.), 16, 1176–1179 (1980).
124. Kelley, J. L., Krochmal, M. P., and Schaeffer, H. J. Pyrimidine acyclic nucleosides. 5-Substituted l-[(2-aminoethoxy)methyl] uracils as candidate antivirals. J. Med. Chem., 24, 472–474 (1981).
125. Kelley, J. L., Kelsey, J. E., Hall, W. R., Krochmal, M. P., and Schaeffer, H. J. Pyrimidine acyclic nucleosides. I-[(2-Hydroxyethoxy)methyl] pyrimidines as candidate antivirals. J. Med. Chem., 24, 753–756 (1981).
126. McCormick, J. E. and McElhinney, R. S. Thio-sugars. Part 6. Seco-nucleosides related to 4-thio-DL-erythrofuranose and 4-thio-DL-ribofuranose. J. Chem. Res. (S), 12–13 (1981).
127. Nakayama, K., Ruth, J. L., and Cheng, Y.-C. Differential effect of nucleoside analog triphosphates on ribonucleotide reductases from uninfected and herpes simplex virus-infected Hela cells. J. Virol., 43, 325–327 (1982).
128. Niedzwicki, J. G., Chu, S. H., el Kouni, M. H., Rowe, E. C., and Cha, S. 5-Benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase. Biochem. Pharmacol., 31, 1857–1861 (1982).
129. Niedzwicki, J. G., el Kouni, M. H., Chu, S. H., and Cha, S. Pyrimidine acyclonucleosides, inhibitors of uridine phosphorylase. Biochem. Pharmacol., 30, 2097–2101 (1981).
130. Ogilvie, K. K. and Gillen, M. F. Ring open analogues of deoxynucleotides. Tetrahedron Lett., 21, 327–330 (1980.
131. Ogilvie, K. K., Dixit, D. M., Radatus, B. K., Smith, K. O., and Galloway, K. S. Synthesis of 5-substituted-l-[[2-hydroxy-l-(hydroxymethyl)ethoxy] - methyl] cytosines. Nucleosides Nucleotides, 2, 147–154 (1983).
132. Ogilvie, K, K. and Proba, Z. A. Synthesis of purine and pyrimidine trihydroxy-acyclonucleosides. Nucleosides Nucleotides, 3, 537–547 (1984).
133. Ogilvie, K. K., Hamilton, R. G., Gillen, M. F., Radatus, B. K., Smith, K. O., and Galloway, K. S. Uracil analogues of the acyclonucleoside 9-[[2-hydroxy-l-(hydroxymethyl)ethoxy] methyl] guanine (BIOLF-62). Can. J. Chem., 62, 16–21 (1984).
134. Ogilvie, K. K., Nguyen-Ba, N., and Hamilton, R. G. A trihydroxy acyclonucleoside series. Can. J. Chem., 62, 1622–1627 (1984)
135. Robins, M. J., Hatfield, P. W., Balzarini, J., and De Clercq, E. Nucleic acid related compounds. 47. Synthesis and biological activities of pyrimidine and purine “acyclic” nucleoside analogues. J. Med. Chem., 27, 1486–1492 (1984).
136. Rosowsky, A., Kim, S.-H., and Wick, M. Synthesis and antitumor activity of an acyclonucleoside derivative of 5-fluorouracil. J. Med. Chem., 24, 1177–1181 (1981).
137. Roveri, P., Cavrini, V., and Gatti, R. Synthesis of some acyclic analogs of pyrimidine nucleosides. Farmaco, Ed. Sci., 39, 346–352 (1984); Chem. Abstr., 101, 111328m (1984).
138. Schroeder, A. C., Hughes, R. G., Jr., and Bloch, A. Synthesis and biological effects of acyclic pyrimidine nucleoside analogues. J. Med. Chem., 24, 1078–1083 (1981)
139. Colla, L., Busson, R., De Clercq, E., and Vanderhaeghe, H. Synthesis of aliphatic nucleoside analogues with potential antiviral activity. Eur. J. Med. Chem. - Chim. Ther., 17, 569–576 (1982).
140. Garuti, L., Ferranti, A., Giovanninetti, G., Scapini, G., Franchi, L., and Landini, M. P. Studies on potential antiviral compounds. XXII. Synthesis and in vitro antiviral activity of l-(hydroxyalkyl)-lH-benzimidazoles. Arch. Pharm., 315, 1007–1013 (1982).
141. Kazimierczuk, Z., Stolarski, R., and Shugar, D. Acyclonucleosides: Acyclobenz-imidazole nucleoside and nucleotide analogs and conformations of the acyclic chains by means of NMR spectroscopy. Acta Biochim. Pol., 31, 33–48 (1984); Chem. Abstr., 101, 105903d (1984).
142. Kelley, J. L., Krochmal, M. P., and Schaeffer, H. J. Purine acyclic nucleosides. Nitrogen isosteres of 9-[(2-hydroxyethoxy)methyl] guanine as candidate antivirals. J. Med. Chem., 24, 1528–1531 (1981).
143. Lin, T.-S. and Liu, M.-C. Synthesis of l-[(2-hydroxy-l-(hydroxymethyl)ethoxy)-methyl]-l,2,4-triazole-3-and 5-carboxamides. Tetrahedron Lett,, 25, 611–612 (1984).
144. MacKenzie, G., Shaw, G., and Robinson, D. H. Purines, pyrimidines, and imidazoles. Part 46. Some acyclic D-arabinose imidazole and purine nucleosides. J. Chem. Soc., Perk. Trans. 1, 1094–1103 (1977)
145. McCormick, J. E. and McElhinney, R. S. Thio sugars. Part 9. Antiviral nucleosides from 4-thio-DL-erythrofuranose and purines and other fused pyrimidines. Proc. R. Ir. Acad., Sect. B, 83, 125–138 (1983); Chem. Abstr., 100, 22947z (1983).
146. Parkin, A. and Harnden, M. R. Acyclic analogues of purine and imidazole nucleosides. J. Heterocycl. Chem., 19, 33–40 (1982).
147. Seela, F. and Kehne, A. 4-Amino-7-(rac-2,3-dihydroxypropyl)-7H-pyrrolo [2,3-d] - pyrimidin — Synthese von acyclotubercidin. Liebigs Ann. Chem., 1940–1945 (1982).
148. Seela, F., Kehne, A., and Winkeler, H.-D. Synthese von acyclo-7-desazaguanosin durch regiospezifische phasentransferalkylierung von 2-amino-4-methoxy-7H-pyrrolo [2,3-d] pyrimidin. Liebigs Ann. Chem., 137–146 (1983).
149. Showalter, H. D. H. and Putt, S. R. Studies related to the total synthesis of pentostatin: An efficient, regiospecific glycosylation of 6,7-dihydro-imidazo [4,5-d] [1,2] diazepin-8(3H)-one and related homologs. Tetrahedron Lett., 22, 3155–3158 (1981).
150. Showalter, H. D. H., Putt, S. R., Borondy, P. E., and Shillis, J. L. Adenosine deaminase inhibitors. Synthesis and biological evaluation of (+)-3,6,7,8-tetrahydro-3-[(2-hydroxyethoxy)methyl] imidazo [4,5-d] [1,3] diazepin-8-ol and some selected C-5 homologues of pentostatin. J. Med. Chem., 26, 1478–1482 (1983)
151. Babin, F., Dinh, T. H., and Igolen, J. Synthese d!analogues acycliques de C-nucleosides. J. Heterocycl. Chem., 20, 1169–1173 (1983).
152. Bergstrom, D. E., Brattesani, A. J., Ogawa, M. K., Reddy, P. A., Schweickert, M. J., Balzarini, J., and De Clercq, E. Antiviral activity of C-5 substituted tubercidin analogues. J. Med. Chem., 27, 285–292 (1984).
153. Chu, C. K. Acyclopyrimidine C-nucleosides. Synthesis of acyclopseudoisocytidine and its derivatives. J. Heterocycl. Chem., 21, 9–11 (1984).
154. Griengl, H. and Gunzl, F. Acyclo analogs of formycin A. J. Heterocycl. Chem., 21, 505–508 (1984).
155. Mel’nik, S. Y., Miniker, T. D., Yartseva, I. V., Nedorezova, T. P., Potapova, G. I., and Preobrazhenskaya, M. N. Synthesis and properties of pyrimidine C-nucleoside acyclic analogs. Bioorg. Khim., 9, 1395–1400 (1983); Chem. Abstr., 100, 68637b (1983).
156. Mitchell, W. L., Hill, M. L., Newton, R. F., Ravenscroft, P., and Scopes, D. I. C. Synthesis of Onucleoside isosteres of 9-(2-hydroxyethoxymethyl)guanine (acyclovir). J. Heterocycl. Chem., 21, 697–699 (1984).